- Drug corporations are sitting on generics--43% of recently approved aren't for sale https://arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/ 40 comments politics
- Drug corporations are sitting on generics--43% of recently approved aren't for sale https://arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/ 39 comments economy
Linking pages
- Big Pharma is using faux generics to keep drug prices high, critics say | Ars Technica https://arstechnica.com/science/2019/08/big-pharma-is-using-faux-generics-to-keep-drug-prices-high-critics-say/ 165 comments
- Drugmakers to pay $70 million over deals to keep cheap generics off the market | Ars Technica https://arstechnica.com/science/2019/07/drug-makers-to-pay-70-million-over-deals-to-keep-cheap-generics-off-the-market/ 82 comments
- The 11 best board games for two players | Ars Technica https://arstechnica.com/gaming/2019/02/our-favorite-two-player-board-games-2019-edition/ 2 comments
- New images of the distant Ultima Thule object have surprised scientists | Ars Technica https://arstechnica.com/science/2019/02/it-looks-like-ultima-thule-may-be-more-of-a-pancake-than-snowman/ 0 comments
Linked pages
- The 11 best board games for two players | Ars Technica https://arstechnica.com/gaming/2019/02/our-favorite-two-player-board-games-2019-edition/ 2 comments
- New images of the distant Ultima Thule object have surprised scientists | Ars Technica https://arstechnica.com/science/2019/02/it-looks-like-ultima-thule-may-be-more-of-a-pancake-than-snowman/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Drug companies are sitting on generics—43% of recently approved aren’t for sale | Ars Technica
See how to search.